Initial clinical consideration of HEM1 deficiency may be challenging due to the clinical heterogeneity at presentation, as well as the phenotypic overlap with other known actinopathies and lymphoproliferative disorders. This evidence concerns the gene NCKAP1L and alpha-actinopathy.